- Home
- ELVN vs VRTS Comparison
ELVN vs VRTS Comparison
Compare ELVN & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | VRTS |
|---|---|---|
| Founded | 2016 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2020 | 1992 |
Fundamental Metrics
Financial Performance| Metric | ELVN | VRTS |
|---|---|---|
| Price | $21.00 | $161.48 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $41.20 | ★ $184.00 |
| AVG Volume (30 Days) | ★ 486.5K | 65.2K |
| Earning Date | 11-12-2025 | 10-24-2025 |
| Dividend Yield | N/A | ★ 5.88% |
| EPS Growth | N/A | ★ 18.44 |
| EPS | N/A | ★ 19.47 |
| Revenue | N/A | ★ $878,336,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.05 | $0.15 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.30 | $142.18 |
| 52 Week High | $25.96 | $252.82 |
Technical Indicators
Market Signals| Indicator | ELVN | VRTS |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 48.30 |
| Support Level | $19.58 | $155.35 |
| Resistance Level | $22.14 | $163.81 |
| Average True Range (ATR) | 1.28 | 5.15 |
| MACD | -0.06 | 1.32 |
| Stochastic Oscillator | 41.37 | 82.30 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About VRTS Virtus Investment Partners Inc.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.